Literature DB >> 28818508

The role of the IL-8 signaling pathway in the infiltration of granulocytes into the livers of patients with alcoholic hepatitis.

S W French1, A S Mendoza2, N Afifiyan1, B Tillman1, E Vitocruz1, B A French1.   

Abstract

BACKGROUND AND AIM: IL-8 (C-X-L motif chemokine ligase 8) and CXCR2 (C-X-C-motif chemokine receptor 2) are up regulated in alcoholic hepatitis (AH) liver biopsies. One of the consequences is the attraction and chemotactic neutrophilic infiltrate seen at the AH stage of alcoholic liver disease.
MATERIALS AND METHODS: Human formalin-fixed, paraffin-embedded (FFPE) liver biopsies from patients who have AH were studied by (2.1) RNA sequencing, (2.2) PCR and (2.3) semi quantitation of specific proteins in biopsy sections using immunohistochemical measurements of antibody fluorescent intensity with morphometric technology.
RESULTS: Immunohistochemistry of IL-8 showed that the expression was increased in the cytoplasm of the hepatocytes in AH liver biopsies compared to the controls. IL-8 and ubiquitin were co-localized in the MDBs. Numerous neutrophils were found throughout and satellitosis of neutrophils around MDBs was present. This suggested that IL-8 may be involved in MDB pathogenesis. RNA seq analysis revealed activation by IL-8 which included neutrophil chemotaxis by LIM domain kinase 2 (LIMK2) (17.5 fold increase) and G protein subunit alpha 15 (GNA15) (27.8 fold increase).
CONCLUSIONS: The formation of MDBs by liver cells showed colocalization of ubiquitin and IL-8 in the MDBs. This suggested that IL-8 in these hepatocytes attracted the neutrophils to form satellitosis. This correlated with up regulation of the proteins downstream from the IL-8 pathways including LIMK2, GNG2 (guanine nucleotide binding proteins) and PIK3CB (phosphatidyl isitol-4, 5-biophosphate-3-kinase, catalytic subunit beta). Published by Elsevier Inc.

Entities:  

Keywords:  Alcoholic hepatitis; CXCL8 (IL-8); CXCR2; Mallory-Denk bodies

Mesh:

Substances:

Year:  2017        PMID: 28818508     DOI: 10.1016/j.yexmp.2017.08.005

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  6 in total

1.  S100B and Inflammatory Cytokine Levels in Blood as Potential Markers of Blood-Brain Barrier Damage and Psychiatric Impairment in Comorbid Hepatitis C Viral Infection and Alcohol Use Disorder.

Authors:  Jennifer M Loftis; Juno Valerio; Jonathan Taylor; Elaine Huang; Rebekah Hudson; Patricia Taylor-Young; Michael Chang; Samuel B Ho; Eric Dieperink; Juan Luis Miranda; Peter Hauser
Journal:  Alcohol Clin Exp Res       Date:  2018-06-28       Impact factor: 3.455

2.  Potential Networks Regulated by MSCs in Acute-On-Chronic Liver Failure: Exosomal miRNAs and Intracellular Target Genes.

Authors:  Jing Zhang; Juan Gao; Dengna Lin; Jing Xiong; Jialei Wang; Junfeng Chen; Bingliang Lin; Zhiliang Gao
Journal:  Front Genet       Date:  2021-04-23       Impact factor: 4.599

3.  IL8 and PMA Trigger the Regulation of Different Biological Processes in Granulocyte Activation.

Authors:  Roxane L Degroote; Maria Weigand; Stefanie M Hauck; Cornelia A Deeg
Journal:  Front Immunol       Date:  2020-01-14       Impact factor: 7.561

4.  Bovine Peripheral Blood Derived Lymphocyte Proteome and Secretome Show Divergent Reaction of Bovine Immune Phenotypes after Stimulation with Pokeweed Mitogen.

Authors:  Kristina J H Kleinwort; Roxane L Degroote; Sieglinde Hirmer; Lucia Korbonits; Lea Lorenz; Armin M Scholz; Stefanie M Hauck; Cornelia A Deeg
Journal:  Proteomes       Date:  2022-02-08

5.  Genetic associations with clozapine-induced myocarditis in patients with schizophrenia.

Authors:  Paul Lacaze; Kathlyn J Ronaldson; Eunice J Zhang; Ana Alfirevic; Hardik Shah; Leah Newman; Maya Strahl; Melissa Smith; Chad Bousman; Ben Francis; Andrew P Morris; Trevor Wilson; Fernando Rossello; David Powell; Vivien Vasic; Robert Sebra; John J McNeil; Munir Pirmohamed
Journal:  Transl Psychiatry       Date:  2020-01-27       Impact factor: 6.222

Review 6.  Abnormal Innate Immunity in Acute-on-Chronic Liver Failure: Immunotargets for Therapeutics.

Authors:  Arshi Khanam; Shyam Kottilil
Journal:  Front Immunol       Date:  2020-10-08       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.